SCHEMBL2943035

SCHEMBL2943035

Cc1c(C)c2c(c(C)c1NC(=O)c1ccc3c(c1)OCO3)C(c1ccc(C(C)C)cc1)C(C)(C)O2

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.43
KMT2A Q03164 5/20 0.43
NPC1 O15118 10/20 0.42
RAB9A P51151 10/20 0.42
PKM P14618 3/20 0.42
CCR6 P51684 1/20 0.42
P2RX4 Q99571 1/20 0.42
P2RX7 Q99572 1/20 0.42
SMN1; SMN2 Q16637 4/20 0.41
RXFP1 Q9HBX9 2/20 0.41
CASP3 P42574 3/20 0.41
SENP7 Q9BQF6 3/20 0.41
SENP6 Q9GZR1 1/20 0.41
NFKB1 P19838 2/20 0.40
NFKB2 Q00653 2/20 0.40
RELA Q04206 2/20 0.40
TP53 P04637 2/20 0.40
MAPT P10636 2/20 0.40
ALDH1A1 P00352 2/20 0.40
NPSR1 Q6W5P4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2913465 0.91 NPC1 (0.47) MEN1KMT2ANPC1RAB9APKM
SCHEMBL27598139 0.87 SMN1; SMN2 (0.42) MEN1KMT2ANPC1RAB9APKM
SCHEMBL2912995 0.84 SMN1; SMN2 (0.39) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL2905201 0.84 LMNA (0.36) KMT2ANPC1RAB9ASMN1; SMN2MAPT
SCHEMBL2905197 0.83 KDM4E (0.35) MEN1KMT2ANPC1RAB9ATP53
SCHEMBL2911427 0.83 LMNA (0.40) KMT2ANPC1RAB9ASMN1; SMN2CASP3
SCHEMBL2910674 0.83 PKM (0.43) MEN1KMT2ANPC1RAB9APKM
SCHEMBL2909184 0.83 RAB9A (0.41) NPC1RAB9ASMN1; SMN2TP53MAPT
SCHEMBL2913347 0.82 RAB9A (0.42) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL2905121 0.82 RAB9A (0.37) KMT2ANPC1RAB9ASMN1; SMN2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 102 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1481679-B1 ANTIDEPRESSANT TAKEDA PHARMACEUTICAL (JP) 2010-08-25 EP disclosed
US-7750037-B2 Antidepressant TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-07-06 US disclosed
US-7491529-B2 Secreted and transmembrane polypeptides and nucleic acids encoding the same GENENTECH, INC. (US) 2009-02-17 US disclosed
EP-1323716-B1 PROMOTERS FOR THE PROLIFERATION AND DIFFERENTIATION OF STEM CELLS AND/OR NEURON PRECURSOR CELLS TAKEDA PHARMACEUTICAL (JP) 2009-01-14 EP disclosed
US-20090012081-A1 Agents for promoting the proliferation or differentiation of stem cells or neural progenitor cells TAKEDA PHARMACEUTICAL COMPANY LTD. (JP) 2009-01-08 US disclosed
US-7456162-B2 Benzofuran derivatives, their production and use TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-11-25 US disclosed
US-7309761-B2 Secreted and transmembrane polypeptides and nucleic acids encoding the same GENENTECH, INC. (US) 2007-12-18 US disclosed
US-7189814-B2 Secreted and transmembrane polypeptides and nucleic acids encoding the same GENENTECH, INC. (US) 2007-03-13 US disclosed
US-7166282-B2 Secreted and transmembrane polypeptides and nucleic acids encoding the same GENENTECH, INC. (US) 2007-01-23 US disclosed
US-7157247-B2 Secreted and transmembrane polypeptides and nucleic acids encoding the same GENENTECH, INC. (US) 2007-01-02 US disclosed
US-20020132252-A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same GENENTECH, INC. 2002-09-19 US disclosed
US-20020127576-A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same GENENTECH, INC. 2002-09-12 US disclosed
US-20020123463-A1 Secreted and transmembrane polypeptides and nucliec acids encodiing the same GENENTECH, INC. 2002-09-05 US disclosed
US-20020072496-A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same GENENTECH, INC. 2002-06-13 US disclosed
US-20020072067-A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same GENENTECH, INC. 2002-06-13 US disclosed
US-20020072092-A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same GENENTECH, INC. 2002-06-13 US disclosed
EP-1210418-A1 SECRETED AND TRANSMEMBRANE POLYPEPTIDES AND NUCLEIC ACIDS ENCODING THE SAME Genentech Inc. (US) 2002-06-05 EP disclosed
EP-1136477-A1 BENZOFURAN DERIVATIVES, PROCESS FOR THE PREPARATION OF THE SAME AND USES THEREOF Takeda Chemical Industries, Ltd. (JP) 2001-09-26 EP disclosed
WO-2000073454-A1 SECRETED AND TRANSMEMBRANE POLYPEPTIDES AND NUCLEIC ACIDS ENCODING THE SAME GENENTECH, INC. (US) 2000-12-07 WO disclosed
WO-1999063088-A2 MEMBRANE-BOUND PROTEINS AND NUCLEIC ACIDS ENCODING THE SAME GENENTECH, INC. (US) 1999-12-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090012081-A1 Agents for promoting the proliferation or differentiation of stem cells or neural progenitor cells NES, MKI67, CCNO MEN1 2906/4885KMT2A 1061/4885NPC1 2467/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.